Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0287-3
Full Text
Open PDFAbstract
Available in full text
Date
November 28, 2018
Authors
Publisher
Springer Science and Business Media LLC